As of December 15, 2025, BRAIN Biotech AG (BNN.DE) reports a EV/EBITDA of -12.33.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing BRAIN Biotech AG's EV/EBITDA to Peers
To better understand BRAIN Biotech AG's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| BRAIN Biotech AG (BNN.DE) | -12.33 |
| OrganoClick AB (ORGC.ST) | 483.37 |
| Eko Export SA (EEX.WA) | 160.72 |
| Photocat A/S (PCAT.ST) | 47.97 |
| Polygiene Group AB (POLYG.ST) | 39.38 |
| Hardide PLC (HDD.L) | 19.15 |
Compared to its competitors, BRAIN Biotech AG's EV/EBITDA is among the lowest compared to peers, which may indicate undervaluation or market concerns about future performance.